海边的曼彻斯特

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_我的网站

A |     8月24日消息，联想拯救者官宣全新C700云游戏掌机，这款设备8月25日正式发布，和腾讯START云游戏深度合作，不用本地下载大体积游戏包，随时随地就能玩3A大作。    Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。    和普通PC掌机不一样，C700不靠本机硬件跑大型游戏，主要走云游戏和串流路线。    接入腾讯START云游戏生态，海量游戏直接点开就能启动，手柄已经完成原生适配，不用自己折腾按键设置。外出坐车、候机的时候，拿起来就可以直接开对局。     云游戏模式下最高可以跑到60帧，延迟最低做到10ms级别。

B |     机身做的很轻薄，整机重量556克，厚度14.9毫米，对比传统Windows掌机轻了接近300克，长时间握持玩游戏手腕压力更小。    正面配备7.82英寸120Hz IPS屏幕，高刷新率在动作游戏里画面滚动更顺滑。

C | 内置8000mAh电池，官方标称连续游戏最长可以达到9小时，出门不用频繁找充电宝。

D |     操控硬件配置到位，配备TMR摇杆、霍尔线性扳机，额外配有背键和小肩键，按键全部支持自定义设置。    除了云游戏之外，还支持联想自研串流功能，可以把家里电脑上的游戏串流到掌机游玩，就算没有外网，也可以本地完成串流。     云游戏掌机算是一条差异化赛道，不用堆高性能芯片，机身可以做的更轻。但游玩体验很依赖网络状态，网络不好的时候，卡顿、延迟问题会直接影响手感，实际表现还要等正式开售之后看实测。

E |     

F |

Current article:http://6sz2lpc.gamajionghuanmuniuzhuanguchu.cyou/ybsde1/liit7na.html

Published on:17:23:34